Andrew Penn

He has completed extensive training in Psychedelic Assisted Psychotherapy at the California Institute for Integral Studies, MAPS, and the Usona Institute. As a member of the UCSF-TrPR Lab (with PI Josh Woolley, MD,PhD), he was a study therapist in the MAPS sponsored Phase 3 study of MDMA-assisted psychotherapy for PTSD and is was a Co-PI in the Phase 2 Usona sponsored study of psilocybin facilitated therapy for major depression.A leading voice for nurses in psychedelic therapy, he is a cofounder of OPENurses, a professional organization for nurses interested in psychedelic research and practice and Additionally, he is a co-author in a recent article in the American Journal of Nursing on psychedelic assisted therapies, the first in 57 years.

Currently, he serves as an Clinical Professor at the University of California-San Francisco School of Nursing where he teaches psychopharmacology and is an Attending Nurse Practitioner at the San Francisco Veterans Administration. He is the Co-chair for Sana Symposium, a leading national CME meeting on psychedelic therapies. Also as a steering committee member for Psych Congress, he has been invited to present internationally on improving medication adherence, cannabis pharmacology, psychedelic assisted psychotherapy, grief psychotherapy, treatment-resistant depression, diagnosis and treatment of bipolar disorder, and the art and science of psychopharmacologic practice. He also keeps regular blogs on all things psychiatric, has been invited to speak at SXSW, the Aspen Health Ideas Festival, and the Singapore Ministry of Health, written for the Los Angeles Times, and interviewed in Forbes, and on the BBC World Service.